The effect of PD-L1 on chemosensitivity was confirmed in BRAFV600E mutant MC38 murine tumor xenografts, where PD-L1 knockout cells were less sensitive to chemotherapy due to the suppression of pro-apoptotic molecules, BIM and BIK, compared to parental cells expressing PD-L1. Here, BCL2L11 is linked to neoplasm.